The proposed research involves defining proximal intracellular events involved in the action of tumor-promoting phorbol esters. Specifically, the biochemical mechanisms of arachidonic acid release and phosphatidylcholine metabolism will be investigated using GH3 rat pituitary cells. Although it has been suggested that stimulation of a phospholipase A2 and phospholipase C, respectively are causative in these events, conclusive evidence is lacking. These events are important because accumulated evidence from many cell types suggests 1) that arachidonic acid and/or metabolites may mediate tumor promotion and 2) phosphatidylcholine metabolism appears specifically related to phorbol ester action. GH3 cells provide an excellent model for these studies because 1) they are a homogeneous cell population permitting unambiguous assignment of changes to a specific cell type and 2) extensive research into protein kinase C, the putative phorbol ester receptor has been performed in these cells. Suggestions as to the enzymic reactions involved from intact cell studies will be confirmed in subcellular fractions. Whether protein kinase C or another cellular acceptor for phorbol esters mediates these events will be studied directly in crude and purified membranes. The effects of diacylglycerols will be compared to phorbol esters on arachidonic acid release and phosphatidylcholine metabolism, cell proliferation, and protein phosphorylation. A potential role for arachidonic acid as an intracellular mediator of phorbol ester and/or diacylglycerol action will be assessed. These studies should further our understanding of the biochemical mechanisms involved in phorbol ester-induced arachidonic acid release and phosphatidylcholine metabolism. Furthermore, and importantly, these studies into proximal intracellular events in phorbol ester action may help elucidate processes involved in the development of some neoplasias.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA042385-02
Application #
3183622
Study Section
Biochemistry Study Section (BIO)
Project Start
1986-04-01
Project End
1989-03-31
Budget Start
1987-04-01
Budget End
1988-03-31
Support Year
2
Fiscal Year
1987
Total Cost
Indirect Cost
Name
Sloan-Kettering Institute for Cancer Research
Department
Type
DUNS #
064931884
City
New York
State
NY
Country
United States
Zip Code
10065
Yin, Xianglei; Zafrullah, Mohammad; Lee, Hyunmi et al. (2009) A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell Physiol Biochem 24:219-30
Zafrullah, Mohammad; Yin, Xianglei; Haimovitz-Friedman, Adriana et al. (2009) Kinase suppressor of Ras transphosphorylates c-Raf-1. Biochem Biophys Res Commun 390:434-40
Zhang, Jianjun; Zafrullah, Mohammad; Yang, Xia et al. (2008) Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotide correlates with tumor drug uptake. Cancer Biol Ther 7:1490-5
Kolesnick, Richard (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110:3-8
Liu, J; Mathias, S; Yang, Z et al. (1994) Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 269:3047-52
Haimovitz-Friedman, A; Kan, C C; Ehleiter, D et al. (1994) Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180:525-35
Kolesnick, R (1994) Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 21:287-97
Mathias, S; Kolesnick, R (1993) Ceramide: a novel second messenger. Adv Lipid Res 25:65-90
Joseph, C K; Byun, H S; Bittman, R et al. (1993) Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed. J Biol Chem 268:20002-6
Mathias, S; Younes, A; Kan, C C et al. (1993) Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259:519-22

Showing the most recent 10 out of 29 publications